Prevention of Progression in Diabetic Nephropathy
Prevention of Progression in Diabetic Nephropathy Phillip M. Hall , MD Abstract In Brief Diabetic nephropathy is the most common cause for end-stage renal disease and for patients entering into chronic dialysis care. It occurs in 25–40% of patients with diabetes. Risk factors include hyperglycemia,...
Gespeichert in:
Veröffentlicht in: | Diabetes spectrum 2006-01, Vol.19 (1), p.18-24 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Prevention of Progression in Diabetic Nephropathy
Phillip M. Hall , MD
Abstract
In Brief
Diabetic nephropathy is the most common cause for end-stage renal disease
and for patients entering into chronic dialysis care. It occurs in
25–40% of patients with diabetes. Risk factors include hyperglycemia,
hypertension, genetic predisposition, glomerular hyperfiltration, proteinuria,
the renal renin-angiotensin system, advanced glycation end-products, and
possibly reduced nephron number and lipid disorders. Prevention of diabetic
nephropathy is crucial. Tight control of diabetes, blood pressure treatment to
systolic pressure of < 130 mmHg, reduction of proteinuria, and treatment
with drugs that inhibit the renin-angiotensin system are all associated with
prevention of or delay in progression of diabetic kidney injury.
Footnotes
Phillip M. Hall, MD, is a consultant in the Department of Nephrology
and Hypertension at the Cleveland Clinic Foundation in Cleveland,
Ohio.
American Diabetes Association |
---|---|
ISSN: | 1040-9165 1944-7353 |
DOI: | 10.2337/diaspect.19.1.18 |